We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Netrin-1 Promotes Atherosclerosis by Inhibiting the Emigration of Macrophages from Plaques

By LabMedica International staff writers
Posted on 22 Feb 2012
Print article
Cardiovascular disease researchers have identified a molecular signal that promotes the blockage of arteries by preventing migration of macrophages away from atherosclerotic plaques.

The signaling molecule is the protein netrin-1. The netrin family is composed mostly of secreted proteins that normally serve as bifunctional signals during development of the embryonic brain. Expressed in the midline of all animals possessing bilateral symmetry, they can act as long or short-range signals during neurogenesis. In order to carry out their functions, netrins interact with specific receptors: DCC or UNC-5 depending on whether they are trying to attract or repel neurons respectively. The C-terminal domain of the netrins is where most of the variation is found between species and it contains different amino acids that allow interaction with specific proteins in extracellular matrix or on cell surface. The differences in terms of structure and function have led to the identifications of several different types of netrins including netrin-1, netrin-3, and netrins-G.

Investigators at the New York University School of Medicine (New York, USA) used fluorescence microscopy techniques to trace the movement of macrophages towards and away from plaques that had formed in arterial tissue taken from mice deficient in the receptor for low-density lipoprotein. Arterial tissues taken from animals genetically engineered to lack macrophage netrin-1expression were also examined.

Results published in the January 8, 2012, online edition of the journal Nature Immunology revealed that acting via its receptor protein, UNC5b, netrin-1 inhibited the migration of macrophages directed by the chemokines CCL2 (chemokine (C-C motif) ligand 2) and CCL19 (chemokine (C-C motif) ligand 19), as well as activation of the actin-remodeling GTPase Rac1 and actin polymerization. Genetically engineered deletion of netrin-1 in macrophages resulted in much less atherosclerosis in mice deficient in the receptor for low-density lipoprotein and promoted the emigration of macrophages from plaques.

The finding that netrin-1 promoted atherosclerosis by retaining macrophages in the artery wall prompted the investigators to conclude that, “Our results establish a causative role for negative regulators of leukocyte migration in chronic inflammation. Local inhibition of such factors may have therapeutic value for the resolution of inflammation in atherosclerosis and other chronic inflammatory diseases.”

Related Links:

New York University School of Medicine



New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.